Cargando…
Predominant SARS-CoV-2 variant impacts accuracy when screening for infection using exhaled breath vapor
BACKGROUND: New technologies with novel and ambitious approaches are being developed to diagnose or screen for SARS-CoV-2, including breath tests. The US FDA approved the first breath test for COVID-19 under emergency use authorization in April 2022. Most breath-based assays measure volatile metabol...
Autores principales: | McCartney, Mitchell M., Borras, Eva, Rojas, Dante E., Hicks, Tristan L., Hamera, Katherine L., Tran, Nam K., Tham, Tina, Juarez, Maya M., Lopez, Enrique, Kenyon, Nicholas J., Davis, Cristina E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731983/ https://www.ncbi.nlm.nih.gov/pubmed/36482179 http://dx.doi.org/10.1038/s43856-022-00221-5 |
Ejemplares similares
-
Metabolite Content Profiling of Bottlenose Dolphin
Exhaled Breath
por: Aksenov, Alexander A., et al.
Publicado: (2014) -
23255 Devices Engineered to Collect Exhaled Breath Condensate (EBC) and their Applications
por: Schmidt, Alexander J., et al.
Publicado: (2021) -
A low cost, easy-to-assemble, open-source modular mobile sampler
design for thermal desorption analysis of breath and environmental
VOCs
por: Chew, Bradley S., et al.
Publicado: (2022) -
Limonene in exhaled breath is elevated in hepatic encephalopathy
por: O’Hara, M E, et al.
Publicado: (2016) -
Microbiota in Exhaled Breath Condensate and the Lung
por: Glendinning, Laura, et al.
Publicado: (2017)